84 related articles for article (PubMed ID: 15755279)
41. Prognostic significance of Fas (CD95/APO-1) positivity in patients with primary nodal diffuse large B-cell lymphoma.
Eser B; Sari I; Canoz O; Altuntas F; Cakmak E; Ozturk A; Ozkan M; Er O; Cetin M; Unal A
Am J Hematol; 2006 May; 81(5):307-14. PubMed ID: 16628716
[TBL] [Abstract][Full Text] [Related]
42. Gender and age-related differences in Burkitt lymphoma--epidemiological and clinical data from The Netherlands.
Boerma EG; van Imhoff GW; Appel IM; Veeger NJ; Kluin PM; Kluin-Nelemans JC
Eur J Cancer; 2004 Dec; 40(18):2781-7. PubMed ID: 15571961
[TBL] [Abstract][Full Text] [Related]
43. Relationship of survivin to clinical drug resistance in Burkitt's lymphoma of the head and neck region.
Zyada MM
Med Oncol; 2011 Dec; 28(4):1565-9. PubMed ID: 20524087
[TBL] [Abstract][Full Text] [Related]
44. Elevation of c-FLIP in castrate-resistant prostate cancer antagonizes therapeutic response to androgen receptor-targeted therapy.
McCourt C; Maxwell P; Mazzucchelli R; Montironi R; Scarpelli M; Salto-Tellez M; O'Sullivan JM; Longley DB; Waugh DJ
Clin Cancer Res; 2012 Jul; 18(14):3822-33. PubMed ID: 22623731
[TBL] [Abstract][Full Text] [Related]
45. Overexpression of FLIPL is an independent marker of poor prognosis in colorectal cancer patients.
Ullenhag GJ; Mukherjee A; Watson NF; Al-Attar AH; Scholefield JH; Durrant LG
Clin Cancer Res; 2007 Sep; 13(17):5070-5. PubMed ID: 17785559
[TBL] [Abstract][Full Text] [Related]
46. CFLAR: A novel diagnostic and prognostic biomarker in soft tissue sarcoma, which positively modulates the immune response in the tumor microenvironment.
Liu X; Li X; Yu S
Oncol Lett; 2024 Apr; 27(4):151. PubMed ID: 38406597
[TBL] [Abstract][Full Text] [Related]
47. Interaction between the Hepatitis B Virus and Cellular FLIP Variants in Viral Replication and the Innate Immune System.
Lee AR; Park YK; Dezhbord M; Kim KH
Viruses; 2022 Feb; 14(2):. PubMed ID: 35215970
[TBL] [Abstract][Full Text] [Related]
48. Moonlighting Proteins Are Important Players in Cancer Immunology.
Adamo A; Frusteri C; Pallotta MT; Pirali T; Sartoris S; Ugel S
Front Immunol; 2020; 11():613069. PubMed ID: 33584695
[TBL] [Abstract][Full Text] [Related]
49. Mechanisms of Apoptosis Resistance to NK Cell-Mediated Cytotoxicity in Cancer.
Sordo-Bahamonde C; Lorenzo-Herrero S; Payer ÁR; Gonzalez S; López-Soto A
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32466293
[TBL] [Abstract][Full Text] [Related]
50. c-FLIP, a Novel Biomarker for Cancer Prognosis, Immunosuppression, Alzheimer's Disease, Chronic Obstructive Pulmonary Disease (COPD), and a Rationale Therapeutic Target.
Safa AR; Kamocki K; Saadatzadeh MR; Bijangi-Vishehsaraei K
Biomark J; 2019; 5(1):. PubMed ID: 32352084
[TBL] [Abstract][Full Text] [Related]
51. Targeting apoptotic caspases in cancer.
Boice A; Bouchier-Hayes L
Biochim Biophys Acta Mol Cell Res; 2020 Jun; 1867(6):118688. PubMed ID: 32087180
[TBL] [Abstract][Full Text] [Related]
52. Superoxide induced inhibition of death receptor signaling is mediated via induced expression of apoptosis inhibitory protein cFLIP.
Hirpara JL; Subramaniam K; Bellot G; Qu J; Seah S; Loh T; Tucker-Kellogg L; Clement MV; Pervaiz S
Redox Biol; 2020 Feb; 30():101403. PubMed ID: 31954371
[TBL] [Abstract][Full Text] [Related]
53. Accelerated degradation of cFLIP
Lee SR; Quan KT; Byun HS; Park I; Kang K; Piao X; Ju E; Ro H; Na M; Hur GM
Sci Rep; 2019 Sep; 9(1):13505. PubMed ID: 31534206
[TBL] [Abstract][Full Text] [Related]
54. ITCH-dependent proteasomal degradation of c-FLIP induced by the anti-HER3 antibody 9F7-F11 promotes DR5/caspase 8-mediated apoptosis of tumor cells.
Le Clorennec C; Lazrek Y; Dubreuil O; Sampaio C; Larbouret C; Lanotte R; Poul MA; Barret JM; Prost JF; Pèlegrin A; Chardès T
Cell Commun Signal; 2019 Aug; 17(1):106. PubMed ID: 31443721
[TBL] [Abstract][Full Text] [Related]
55. E3 ubiquitin ligases and deubiquitinases as modulators of TRAIL-mediated extrinsic apoptotic signaling pathway.
Woo SM; Kwon TK
BMB Rep; 2019 Feb; 52(2):119-126. PubMed ID: 30638181
[TBL] [Abstract][Full Text] [Related]
56. Regulation of the antiapoptotic protein cFLIP by the glucocorticoid Dexamethasone in ALL cells.
Kleinesudeik L; Rohde K; Fulda S
Oncotarget; 2018 Mar; 9(23):16521-16532. PubMed ID: 29662664
[TBL] [Abstract][Full Text] [Related]
57. Distinct Activation Mechanisms of NF-κB Regulator Inhibitor of NF-κB Kinase (IKK) by Isoforms of the Cell Death Regulator Cellular FLICE-like Inhibitory Protein (cFLIP).
Baratchian M; Davis CA; Shimizu A; Escors D; Bagnéris C; Barrett T; Collins MK
J Biol Chem; 2016 Apr; 291(14):7608-20. PubMed ID: 26865630
[TBL] [Abstract][Full Text] [Related]
58. Lesser-Known Molecules in Ovarian Carcinogenesis.
Lozneanu L; Cojocaru E; Giuşcă SE; Cărăuleanu A; Căruntu ID
Biomed Res Int; 2015; 2015():321740. PubMed ID: 26339605
[TBL] [Abstract][Full Text] [Related]
59. BIN1 tumor suppressor regulates Fas/Fas ligand-mediated apoptosis through c-FLIP in cutaneous T-cell lymphoma.
Esmailzadeh S; Huang Y; Su MW; Zhou Y; Jiang X
Leukemia; 2015 Jun; 29(6):1402-13. PubMed ID: 25578476
[TBL] [Abstract][Full Text] [Related]
60. Roles of c-FLIP in Apoptosis, Necroptosis, and Autophagy.
Safa AR
J Carcinog Mutagen; 2013; Suppl 6():. PubMed ID: 25379355
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
